Cite
HARVARD Citation
Mease, P. et al. (n.d.). AB0802 SAFETY PROFILES OF IXEKIZUMAB VERSUS ADALIMUMAB: 52-WEEK RESULTS FROM A HEAD-TO-HEAD COMPARISON IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS. Annals of the rheumatic diseases. pp. 1701-1702. [Online].